Back to nmtc1.com

We are developing new minimally invasive and high-definition electrodes based on our thin film electrode platform for diagnostic and therapeutic neurological applications.

Investor Documents

Events

  • Fiscal Third Quarter 2026 Earnings Conference Call

    August 13, 2026
    8:30 AM ET

    U.S. Dial-In (Toll Free): 888-506-0062
    International Dial-In: 973-528-0011
    Participant Access Code: 549778

    Webcast
View All Events

Press Releases

See all press releases

Latest Quarterly Results

Q2 2026

Quarter Ended March 31, 2026
View Presentation

OneRF: Highlight of Clara’s Successful Treatment

After many years of Drug Resistant Epilepsy she has been seizure free for months after OneRF ablation treatment. Hear about her Epilepsy journey and OneRF treatment.

NeuroOne is a medical technology company that is transforming the diagnosis and treatment of neurological disorders

FDA-Cleared

3 FDA 510(k) cleared products for use in the brain, with the only FDA cleared product that uses the same sEEG electrode for both diagnostic and therapeutic applications. Additional submissions planned for 2025.

Patented Technology

Patented and disruptive technology unlocking multi-billion markets in neurology.

Exclusive Partnerships

Exclusive partnership with Zimmer Biomet, the global leader in robotic surgical technology, and the Mayo Clinic.

Back to top